Genpact
G NYSE· Data Processing & Outsourced Services
Last close · Oct 27, 2026
$39.20
KIRA · Stoqly’s AI analyst, in plain words
- Genpact had $5.1B of revenue in fiscal 2025, up 6.6% on the year before. Over five years, revenue changed +6.5% a year on average.
- Its operating margin was 14.8%, up 0.0 pts: of every 100 in sales, about 15 is left after running the business.
- Genpact made $553M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 10.4% a year.
- Free cash flow was $735M in fiscal 2025, 14.5% of revenue.
- Genpact returned $118M to shareholders in fiscal 2025, 16% of free cash flow. The diluted share count fell 2.1%.
- Genpact owes $358M more than it holds in cash, about 0.4 years of operating profit.
Market cap
$6.7B
P/E
11.6x
Revenue
$5.1B
Net income
$553M
Free cash flow
$735M
Operating margin
14.8%
Genpact in 30 seconds · fiscal 2025
Are sales growing?
+6.6%
Yes. Sales grew 6.6% last year.
Does it make a profit?
10.9%
Yes. It keeps 10.9% of every sale as profit.
Does profit turn into cash?
14.5%
Yes. 14.5% of sales ends up as free cash.
Is debt under control?
0.4x
Yes. It could repay its debt with 0.4 years of operating profit.
How healthy are the accounts?
7 / 9
Solid. It passes 7 of 9 health tests.
How is the share priced?
11.6x
One share costs 11.6 times its yearly profit per share. Typical for its sector: 26.0x.
What Genpact does
Genpact runs business operations for large companies and builds AI and data tools for them. It began about 25 years ago as General Electric's in-house back-office unit. Clients pay it to handle work such as accounts payable and collections, supply chain and procurement, insurance and banking back-office tasks, healthcare claims, and customer support. It also advises on process design and builds software that uses AI agents (programs that can carry out tasks on their own). It has over 146,500 employees working in more than 35 countries. In 2025 its net revenues were $5.1 billion. It splits that revenue two ways. Advanced Technology Solutions (data and AI, digital technology, advisory and agentic services) was a smaller share, and Core Business Services (decision support, technology services and digital operations) was the larger. Its three reportable segments are Financial Services, Consumer and Healthcare, and High Tech and Manufacturing.
Biggest risks, in its own words
- Changes in AI that could shift its market, and the risk that its own use of AI does not succeed.
- Heavy dependence on India for a large part of its assets, employees and operations.
- Revenue concentrated in North America and Europe and in a few client industries.
- Fixed-price and long-term contracts that may be priced wrongly and cut profit.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Legal name
- Genpact Limited
- CIK
- 0001398659
Genpact · G
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $4.0B | $4.4B | $4.5B | $4.8B | $5.1B |
| Revenue growth | 8.4% | 8.7% | 2.4% | 6.5% | 6.6% |
| Gross margin | 35.6% | 35.2% | 35.1% | 35.5% | 36.0% |
| Operating margin | 12.7% | 11.5% | 14.1% | 14.7% | 14.8% |
| Net income | $369M | $353M | $631M | $514M | $553M |
| Net margin | 9.2% | 8.1% | 14.1% | 10.8% | 10.9% |
| Diluted EPS | $1.91 | $1.88 | $3.41 | $2.85 | $3.13 |
| Cash | |||||
| Cash from operations | $694M | $444M | $491M | $615M | $813M |
| Capital expenditure | $53.3M | $50.6M | $55.4M | $82.8M | $78.2M |
| Free cash flow | $641M | $393M | $435M | $533M | $735M |
| FCF margin | 15.9% | 9.0% | 9.7% | 11.2% | 14.5% |
| Dividends paid | $80.5M | $91.8M | $100M | $109M | $118M |
| Share buybacks | $298M | $214M | $226M | $253M | $0.0M |
| Share count change | −1.4% | −2.5% | −1.6% | −2.5% | −2.1% |
| Debt and strength | |||||
| Cash and short-term investments | $900M | $647M | $584M | $672M | $1.2B |
| Debt incl. finance leases | $1.7B | $1.5B | $1.3B | $1.2B | $1.6B |
| Shareholders' equity | $1.9B | $1.8B | $2.2B | $2.4B | $2.5B |
| Net debt / EBITDA | 1.2x | 1.3x | 1.0x | 0.7x | 0.4x |
| Current ratio | 1.5x | 1.6x | 1.4x | 2.2x | 1.7x |
| Interest coverage | 8.7x | 8.6x | 9.5x | 8.8x | 10.2x |
| Returns and quality | |||||
| Return on capital | 14.2% | 14.3% | 22.6% | 18.0% | 19.4% |
| Return on equity | 19.8% | 19.0% | 31.0% | 22.2% | 22.4% |
| Piotroski F-score | 8 | 7 | 6 | 8 | 7 |
| Altman Z'' | 2.6 | 3.0 | 3.3 | 4.2 | 3.6 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$8.1M
7 insiders
Of sales under plans
18%
$1.5M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Genpact · G
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Genpact G | $6.7B | 6.6% | 14.8% | 14.5% | 19.4% | 11.6x | 7 |
| Maximus MMS | $3.3B | 2.4% | 9.7% | 6.7% | 13.6% | 9.2x | 7 |
| Broadridge Financial Solutio... BR | $20.7B | 8.5% | 17.4% | 17.1% | 18.3% | — | 9 |
| EXL EXLS | $6.4B | 13.6% | 15.0% | 14.3% | 28.4% | 26.2x | 8 |
| Carlisle Companies CSL | $14.1B | 0.3% | 20.0% | 19.3% | 21.9% | 20.0x | 6 |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $39.20 a share, the company is worth $6.7B: 11.6 times its earnings of the last four quarters.
Genpact grew sales faster than 2 of its 4 similar companies. Its P/E is higher than 1 of 3.
Source: SEC EDGAR XBRL filings (CIK 0001398659). Data updated October 11, 2026. For information only — not investment advice. Check the original filings before relying on any figure.